“…, probe design and technology development) will bring unprecedented opportunities to facilitate drug discovery and personalized medicine. 306,307 For example, new probe and assay designs with spatially precise photo-proximity labeling 308 and dynamic ratiometric imaging 309 are likely to further enhance the specificity, sensitivity, and accuracy of small-molecule probes to generate highly reliable data for drug evaluation, against complex background of different biological specimens. Likewise, technology advances in multiplexed microfluidic systems 310 and cycling imaging 311 which enhance information acquisition, at a high molecular resolution and processing throughput, can reveal previously masked signatures, generate multiparametric and multipopulation analysis, and establish disease-reflective biomarker composites.…”